Evidence map›Paper›PMID 28087486›Full record

ArticleActa biomaterialia2017

Enhanced articular cartilage by human mesenchymal stem cells in enzymatically mediated transiently RGDS-functionalized collagen-mimetic hydrogels.

Paresh A Parmar, Jean-Philippe St-Pierre, Lesley W Chow, Christopher D Spicer, Violet Stoichevska, Yong Y Peng, Jerome A Werkmeister, John A M Ramshaw, Molly M Stevens

Open access · hybridAbstract read
In one paragraph

Article in Acta biomaterialia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Recombinant collagen hydrogels induced by disulfide bonds.Journal of biomedical materials research. Part A · 2022
    Article
  12. Prokaryotic Collagen-Like Proteins as Novel Biomaterials.Frontiers in bioengineering and biotechnology · 2022
    Review
  13. Article
  14. Review
  15. Review
  16. Tunable Protein Hydrogels: Present State and Emerging Development.Advances in biochemical engineering/biotechnology · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Paresh A ParmarDepartment of Materials, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Department of Bioengineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Institute of Biomedical Engineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; CSIRO Manufacturing, Bayview Avenue, Clayton, Victoria 3169, Australia; Division of Biomaterials and Regenerative Medicine, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Scheeles väg 2, 17177 Stockholm, Sweden.
Jean-Philippe St-PierreDepartment of Materials, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Department of Bioengineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Institute of Biomedical Engineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom.
Lesley W ChowDepartment of Materials, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Department of Bioengineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Institute of Biomedical Engineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom.
Christopher D SpicerDepartment of Materials, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Department of Bioengineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Institute of Biomedical Engineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom.
Violet StoichevskaCSIRO Manufacturing, Bayview Avenue, Clayton, Victoria 3169, Australia.
Yong Y PengCSIRO Manufacturing, Bayview Avenue, Clayton, Victoria 3169, Australia.
Jerome A WerkmeisterCSIRO Manufacturing, Bayview Avenue, Clayton, Victoria 3169, Australia.
John A M RamshawCSIRO Manufacturing, Bayview Avenue, Clayton, Victoria 3169, Australia.
Molly M StevensDepartment of Materials, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Department of Bioengineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Institute of Biomedical Engineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Division of Biomaterials and Regenerative Medicine, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Scheeles väg 2, 17177 Stockholm, Sweden. Electronic address: m.stevens@imperial.ac.uk.
CSIRO Manufacturing · AUImperial College London · GBKarolinska Institutet · SE

Funding

Wellcome Trust 088844Wellcome Trust 097816Wellcome Trust 097816/Z/11/AWellcome Trust 104931Wellcome Trust 104931/Z/14/Z
6 · The paper itself

Abstract

Recapitulation of the articular cartilage microenvironment for regenerative medicine applications faces significant challenges due to the complex and dynamic biochemical and biomechanical nature of native tissue. Towards the goal of biomaterial designs that enable the temporal presentation of bioactive sequences, recombinant bacterial collagens such as Streptococcal collagen-like 2 (Scl2) proteins can be employed to incorporate multiple specific bioactive and biodegradable peptide motifs into a single construct. Here, we first modified the backbone of Scl2 with glycosaminoglycan-binding peptides and cross-linked the modified Scl2 into hydrogels via matrix metalloproteinase 7 (MMP7)-cleavable or non-cleavable scrambled peptides. The cross-linkers were further functionalized with a tethered RGDS peptide creating a system whereby the release from an MMP7-cleavable hydrogel could be compared to a system where release is not possible. The release of the RGDS peptide from the degradable hydrogels led to significantly enhanced expression of collagen type II (3.9-fold increase), aggrecan (7.6-fold increase), and SOX9 (5.2-fold increase) by human mesenchymal stem cells (hMSCs) undergoing chondrogenesis, as well as greater extracellular matrix accumulation compared to non-degradable hydrogels (collagen type II; 3.2-fold increase, aggrecan; 4-fold increase, SOX9; 2.8-fold increase). Hydrogels containing a low concentration of the RGDS peptide displayed significantly decreased collagen type I and X gene expression profiles, suggesting a major advantage over either hydrogels functionalized with a higher RGDS peptide concentration, or non-degradable hydrogels, in promoting an articular cartilage phenotype. These highly versatile Scl2 hydrogels can be further manipulated to improve specific elements of the chondrogenic response by hMSCs, through the introduction of additional bioactive and/or biodegradable motifs. As such, these hydrogels have the possibility to be used for other applications in tissue engineering. STATEMENT OF SIGNIFICANCE: Recapitulating aspects of the native tissue biochemical microenvironment faces significant challenges in regenerative medicine and tissue engineering due to the complex and dynamic nature of the tissue. The ability to take advantage of, mimic, and modulate cell-mediated processes within novel naturally-derived hydrogels is of great interest in the field of biomaterials to generate constructs that more closely resemble the biochemical microenvironment and functions of native biological tissues such as articular cartilage. Towards this goal, the temporal presentation of bioactive sequences such as RGDS on the chondrogenic differentiation of human mesenchymal stem cells is considered important as it has been shown to influence the chondrogenic phenotype. Here, a novel and versatile platform to recreate a high degree of biological complexity is proposed, which could also be applicable to other tissue engineering and regenerative medicine applications.

Indexed as

Bacterial ProteinsBiomimetic MaterialsCartilage, ArticularCells, CulturedCell SurvivalChondrogenesisCollagenCompressive StrengthDNAExtracellular MatrixGene Expression RegulationGlycosaminoglycansHumansHydrogel, Polyethylene Glycol DimethacrylateKineticsMatrix Metalloproteinase 7arginyl-glycyl-aspartyl-serineBacterial ProteinsCollagenDNAGlycosaminoglycansHydrogel, Polyethylene Glycol DimethacrylateMatrix Metalloproteinase 7OligopeptidesScl2 protein, StreptococcusBiodegradationBiomimetic materialCartilage tissue engineeringHydrogelMesenchymal stem cellRGDS

Identifiers

PMID28087486
PMCPMC5360098
OpenAlexW2569250350

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.